Dutch Hospital Wins Innovation Prize for Reducing Check-Ups for Slow-Growing Lymphatic Cancer

Hematologists at the Albert Schweitzer Hospital in Dordrecht, Netherlands, have been awarded the annual hematology innovation prize from the Dutch Journal of Haematology (NTvH) for their research into optimizing care for patients with indolent (slow-growing) lymphatic cancer. The team, including Physician Assistant Hematology Jantina Kortleve, developed a patient-centered approach that explores whether individuals with this type of cancer can safely reduce the frequency of routine hospital check-ups.

Understanding the Current Standard of Care

Traditionally, patients with a slow-growing form of lymphatic cancer typically undergo hospital check-ups once or twice a year. However, research suggests that many of these patients do not require treatment for extended periods. This led the Albert Schweitzer Hospital to investigate a more flexible and patient-focused model.

The “Less is More” Approach

The innovative approach implemented at the Albert Schweitzer Hospital empowers patients to have greater control over scheduling appointments with their specialists. This change is implemented in close consultation with each patient to ensure their comfort and well-being. The research aims to determine not only the medical safety and responsibility of fewer appointments but also the impact on the patient’s sense of security and overall quality of life.

Recognition and Future Implications

The Dutch Journal of Haematology’s innovation prize recognizes this forward-thinking approach to cancer care. The goal is not to diminish the level of care provided, but rather to tailor it to the individual needs of each patient. This model prioritizes providing care that is both effective and considerate of the patient’s experience.

About the Dutch Journal of Haematology (NTvH)

The Dutch Journal of Haematology (NTvH) is a peer-reviewed medical journal published eight times a year. It serves as the official platform for the Dutch Society of Haematology (NVvH) and the clinical research organization HOVON. The journal focuses on providing practical and informative insights into the latest medical developments in the field of hematology for clinicians. The current Chief Editor is dr. C.W. Choi, internist-hematoloog, UMCG, Groningen, and the Vice Chief Editor is dr. L.F.D. Van Vulpen, Internist-hematoloog, UMCU, Utrecht. Learn more about the NTvH.